23:28:18 EDT Wed 16 Jun 2021
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for C:TBP from 2020-06-17 to 2021-06-16 - 84 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2021-06-02 10:58C:TBPTetra Bio-Pharma Inc0.325News ReleaseTetra's Reduvo enters final review with Health Canada
2021-05-31 19:51C:TBPTetra Bio-Pharma Inc0.355Prospectus ApprovedTetra Bio-Pharma to list additional shares on TSX
2021-05-28 21:00C:TBPTetra Bio-Pharma Inc0.37News ReleaseTetra Bio-Pharma holders approve all matters at AGSM
2021-05-28 09:26C:TBPTetra Bio-Pharma Inc0.37News ReleaseTetra enrolls first patient in Reborn1 trial
2021-05-21 10:14C:TBPTetra Bio-Pharma Inc0.365News ReleaseTetra Bio-Pharma underwriters exercise greenshoe
2021-05-18 11:37C:TBPTetra Bio-Pharma Inc0.375News ReleaseTetra to nominate Kim, Auld to board
2021-05-17 12:46C:TBPTetra Bio-Pharma Inc0.38News ReleaseTetra Bio-Pharma closes $10-million bought deal
2021-05-13 18:46C:TBPTetra Bio-Pharma Inc0.325Prospectus ApprovedTetra Bio-Pharma to list additional shares May 17
2021-05-11 09:06C:TBPTetra Bio-Pharma Inc0.46News ReleaseTetra Bio-Pharma increases Plenitude enrolment
2021-05-10 17:39C:TBPTetra Bio-Pharma Inc0.46News ReleaseTetra Bio-Pharma arranges $10-million financing
2021-05-06 11:13C:TBPTetra Bio-Pharma Inc0.375News ReleaseTetra Bio-Pharma begins Reborn1 trial
2021-05-05 07:12C:TBPTetra Bio-Pharma Inc0.475News ReleaseTetra products to be sold by DanCann in Europe
2021-05-04 11:34C:TBPTetra Bio-Pharma Inc0.49News ReleaseTetra Bio-Pharma receives extension for PPP-003v trials
2021-05-03 09:35C:TBPTetra Bio-Pharma Inc0.49News ReleaseTetra receives Health Canada licence for Reduvo
2021-04-28 06:03C:TBPTetra Bio-Pharma Inc0.365News ReleaseTetra requests Malta Medicines opinion on Qixleef
2021-04-23 09:14C:TBPTetra Bio-Pharma Inc0.26News ReleaseTetra ships Qixleef to U.S. for Reborn1 study
2021-04-15 06:38C:TBPTetra Bio-Pharma Inc0.19News ReleaseTetra Bio-Pharma wins U.S. patent for IC treatment
2021-04-14 21:52C:TBPTetra Bio-Pharma Inc0.18SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2021-04-14 21:52C:TBPTetra Bio-Pharma Inc0.18SEDAR MD & ASEDAR MD & A
2021-04-14 07:45C:TBPTetra Bio-Pharma Inc0.18News ReleaseTetra responds to HC request for more Reduvo info
2021-04-05 06:06C:TBPTetra Bio-Pharma IncNews ReleaseTetra's ARDS-003 receives FDA nod for clinical dev
2021-04-01 06:08C:TBPTetra Bio-Pharma IncNews ReleaseTetra Bio-Pharma receives HC nod for DEL
2021-03-30 06:03C:TBPTetra Bio-Pharma IncNews ReleaseTetra's ARDS-003 clinical trial application gets HC nod
2021-03-26 06:30C:TBPTetra Bio-Pharma IncNews ReleaseTetra starts other research projects on ARDS-003
2021-03-18 06:18C:TBPTetra Bio-Pharma IncNews ReleaseTetra receives compliance notice for DEL from HC
2021-03-15 06:01C:TBPTetra Bio-Pharma Inc0.18News ReleaseTetra Bio-Pharma's Dronabinol NDS completes screening
2021-03-08 11:12C:TBPTetra Bio-Pharma Inc0.16News ReleaseTetra Bio-Pharma corrects 2026 peak sales estimate
2021-03-02 12:33C:TBPTetra Bio-Pharma Inc0.18News ReleaseTetra Bio-Pharma closes $14.42M public offering
2021-03-01 21:58C:TBPTetra Bio-Pharma Inc0.19Warrants Called to TradeTetra Bio-Pharma warrants to trade on TSX March 2
2021-03-01 21:54C:TBPTetra Bio-Pharma Inc0.19Prospectus ApprovedTetra Bio-Pharma to list additional shares March 2
2021-02-25 10:01C:TBPTetra Bio-Pharma Inc0.195News ReleaseTetra to distribute Reduvo Adversa, QIXLEEF in Europe
2021-02-24 21:48C:TBPTetra Bio-Pharma Inc0.20SEDAR Annual Information FormSEDAR Annual Information Form
2021-02-23 12:57C:TBPTetra Bio-Pharma Inc0.20News ReleaseTetra Bio-Pharma increases bought deal to $12.54M
2021-02-23 07:57C:TBPTetra Bio-Pharma Inc0.26Resume TradingTetra Bio-Pharma to resume at open
2021-02-22 16:55C:TBPTetra Bio-Pharma Inc0.26News ReleaseTetra Bio-Pharma arranges $10.01M bought deal offering
2021-02-22 16:26C:TBPTetra Bio-Pharma Inc0.26Halt TradingTetra Bio-Pharma halted at 1:21 p.m. PT
2021-02-19 00:17C:TBPTetra Bio-Pharma Inc0.26Warrants ExpireTetra Bio-Pharma warrants to expire March 5
2021-02-17 08:35C:TBPTetra Bio-Pharma Inc0.315SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2021-02-17 08:35C:TBPTetra Bio-Pharma Inc0.315SEDAR MD & ASEDAR MD & A
2021-02-03 10:25C:TBPTetra Bio-Pharma Inc0.21News ReleaseTetra Bio-Pharma closes $1.88-million private placement
2021-02-03 08:04C:TBPTetra Bio-Pharma Inc0.21News ReleaseTetra Bio-Pharma creates Enjouca subsidiary
2021-01-29 07:23C:TBPTetra Bio-Pharma Inc0.18News ReleaseTetra Bio-Pharma receives FDA clearance for IND
2021-01-28 00:33C:TBPTetra Bio-Pharma Inc0.16News ReleaseTetra Bio-Pharma arranges $1.9M private placement
2020-12-30 08:12C:TBPTetra Bio-Pharma Inc0.19News ReleaseTetra files new drug submission for Reduvo in Canada
2020-12-21 08:18C:TBPTetra Bio-Pharma Inc0.185News ReleaseTetra Bio receives recommendation for gov't funding
2020-12-16 07:58C:TBPTetra Bio-Pharma Inc0.19News ReleaseTetra completes Type B FDA meeting re CINV drug
2020-12-07 08:46C:TBPTetra Bio-Pharma IncNews ReleaseTetra expects $675M (U.S.) in QIXLEEF net sales by 2027
2020-12-02 09:13C:TBPTetra Bio-Pharma Inc0.195News ReleaseTetra Bio-Pharma completes ARDS-003 toxicology program
2020-11-16 07:28C:TBPTetra Bio-Pharma IncNews ReleaseTetra Bio-Pharma to submit drug market app in 2020
2020-11-04 07:17C:TBPTetra Bio-Pharma Inc0.17News ReleaseTetra pegs ARDS-003 revenue of $500M (U.S.) by 2026
2020-11-02 14:00C:TBPTetra Bio-Pharma Inc0.175News ReleaseTetra acquires 14.62 million Mondias Natural shares
2020-10-28 08:23C:TBPTetra Bio-Pharma Inc0.165News ReleaseTetra Bio-Pharma completes sale of Lumiera Health
2020-10-22 07:58C:TBPTetra Bio-Pharma Inc0.17News ReleaseTetra Bio-Pharma signs COVID-19 research deal
2020-10-21 08:32C:TBPTetra Bio-Pharma Inc0.165News ReleaseTetra signs amended deal re Adversa technology
2020-10-20 08:29C:TBPTetra Bio-Pharma Inc0.155News ReleaseTetra's ARDS-003 reduces cytokines in animal study
2020-10-14 22:01C:TBPTetra Bio-Pharma Inc0.155SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2020-10-14 22:01C:TBPTetra Bio-Pharma Inc0.155SEDAR MD & ASEDAR MD & A
2020-10-07 09:21C:TBPTetra Bio-Pharma Inc0.16News ReleaseTetra to submit DIN application for dronabinol in Q4
2020-09-30 11:53C:TBPTetra Bio-Pharma Inc0.18News ReleaseTetra to acquire Cdn distribution rights for dronabinol
2020-09-30 11:45C:TBPTetra Bio-Pharma Inc0.14Resume TradingTetra Bio-Pharma to resume at 9:15 a.m. PT
2020-09-30 11:18C:TBPTetra Bio-Pharma Inc0.14Halt TradingTetra Bio-Pharma halted at 8:16 a.m. PT
2020-09-17 10:55C:TBPTetra Bio-Pharma Inc0.17News ReleaseTetra Bio appoints Weil, Norton directors, Wood COO
2020-09-11 09:08C:TBPTetra Bio-Pharma Inc0.18News ReleaseTetra Bio-Pharma appoints Boily as CFO
2020-09-04 09:35C:TBPTetra Bio-Pharma Inc0.19News ReleaseTetra appoints Scott as senior VP commercial strategy
2020-09-02 09:49C:TBPTetra Bio-Pharma Inc0.20News ReleaseTetra Bio-Pharma begins Plenitude trial for QIXLEEF
2020-08-27 10:37C:TBPTetra Bio-Pharma Inc0.19News ReleaseTetra Bio-Pharma talks QIXLEEF study data
2020-08-18 09:22C:TBPTetra Bio-Pharma Inc0.20News ReleaseTetra Bio-Pharma hires Dalton for drug manufacturing
2020-08-17 10:12C:TBPTetra Bio-Pharma Inc0.195News ReleaseMondias, Tetra Bio-Pharma firm up Lumiera deal
2020-08-06 11:54C:TBPTetra Bio-Pharma Inc0.215News ReleaseTetra Bio-Pharma to create European unit
2020-07-30 21:10C:TBPTetra Bio-Pharma Inc0.21New ListingTetra Bio-Pharma to trade on TSX Aug. 4
2020-07-30 17:54C:TBPTetra Bio-Pharma Inc0.21Shares Delisted from TSX-VTetra Bio-Pharma to be delisted from TSX-V
2020-07-30 14:07C:TBPTetra Bio-Pharma Inc0.19News ReleaseTetra Bio-Pharma to begin trading on TSX Aug. 4
2020-07-28 12:06C:TBPTetra Bio-Pharma IncNews ReleaseTetra Bio-Pharma plans to resume Plenitude trial in Q3
2020-07-27 10:23C:TBPTetra Bio-Pharma Inc0.19News ReleaseTetra Bio-Pharma talks Lumiera sale, pharma focus
2020-07-23 11:56C:TBPTetra Bio-Pharma Inc0.205News ReleaseTetra to sell subsidiary Lumiera to Mondias
2020-07-20 21:52C:TBPTetra Bio-Pharma Inc0.215SEDAR MD & ASEDAR MD & A
2020-07-20 21:46C:TBPTetra Bio-Pharma Inc0.215SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2020-07-16 11:34C:TBPTetra Bio-Pharma Inc0.23News ReleaseTetra pleased with FDA's review of ARDS-003 application
2020-07-15 12:36C:TBPTetra Bio-Pharma Inc0.195News ReleaseTetra Bio-Pharma gets OK for listing on TSX
2020-07-09 10:05C:TBPTetra Bio-Pharma Inc0.20News ReleaseTetra Bio-Pharma appoints Edgett as adviser
2020-06-25 09:19C:TBPTetra Bio-Pharma Inc0.21News ReleaseTetra Bio-Pharma grants options to buy 1.53 M shares
2020-06-23 21:27C:TBPTetra Bio-Pharma Inc0.22Prospectus ApprovedTetra Bio-Pharma prospectus offering
2020-06-22 10:54C:TBPTetra Bio-Pharma Inc0.215News ReleaseTetra Bio-Pharma director Drohan resigns
2020-06-17 09:00C:TBPTetra Bio-Pharma Inc0.225News ReleaseTetra Bio-Pharma begins ARDS-003 toxicology studies